About RanD
RanD is a company based in Medolla (Italy) founded in 1999 was acquired by Continental Investment Partners in October 2024.. RanD offers products and services including Performer 3, Performer HT, and Perfusion Service. RanD operates in a competitive market with competitors including ChemoTech, Nativis, IGEA and Papyrus Therapeutics, among others.
- Headquarter Medolla, Italy
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Rand S.P.A.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Continental Investment Partners
(Oct 15, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RanD
RanD offers a comprehensive portfolio of products and services, including Performer 3, Performer HT, and Perfusion Service. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Advanced medical system for hyperthermic perfusion in oncology treatments.
System designed for hyperthermic intraperitoneal chemotherapy procedures.
Provides support for extracorporeal circulation in surgical applications.
Funding Insights of RanD
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in RanD
RanD has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Continental Investment Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in companies and real estate operations are facilitated.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by RanD
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - RanD
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Rand Comparisons
Competitors of RanD
RanD operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ChemoTech, Nativis, IGEA and Papyrus Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of electroporation devices for the treatment of cancer
|
|
| domain | founded_year | HQ Location |
Developer of a therapeutic device for the treatment of cancer
|
|
| domain | founded_year | HQ Location |
Orthopedic medical devices to promote reparative osteogenesis and joint protection
|
|
| domain | founded_year | HQ Location |
Develops therapies for tumor suppression in various cancers through scientific research.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about RanD
When was RanD founded?
RanD was founded in 1999.
Where is RanD located?
RanD is headquartered in Medolla, Italy. It is registered at Medolla, Emilia-romagna, Italy.
What does RanD do?
RanD was established in 1999 in Medolla, Italy, within the medical devices sector. Focus is placed on surgical oncology through the creation of innovative systems utilizing extracorporeal circulation technologies. Operations encompass the provision of products for liver support, cardiopulmonary support, and dialysis. Activities are centered on advancing these technologies for clinical applications in oncology and related fields.
What products or services does RanD offer?
RanD offers Performer 3, Performer HT, and Perfusion Service.
Who are RanD's investors?
RanD has 1 investor. Key investors include Continental Investment Partners.